RESUMO
The level of antibodies to thyroglobulin (Ab-TG), microsomal fraction (Ab-ME) and plasma membranes of thyrocytes (PMT) was investigated in patients with Basedow's disease using the DELFIA method. Altogether 81 patients were investigated before the onset of therapy, of them 44-3 and 12 mos. after thiamazole therapy. Before the onset of therapy among 81 patients Ab-MF were detected in 55, Ab-TG--in 69, Ab-PMT--in 70, exceeding considerably (p less than 0.05) the respective indices in the control group. During investigation of 44 patients the following indices were detected in 3 mos.: Ab-TG--in 35 patients, Ab-MF--in 26, and Ab-PMT--in 35; in 12 mos.: these indices were detected in 21, 15 and 23 patients, respectively. A significant decrease in the detectability (p less than 0.05) of Ab-TG, Ab-MF and Ab-PMT was noted one year after the onset of thiamazole therapy.